Xavier, Serene https://orcid.org/0000-0002-9786-4862
Nguyen, Vivian
Khairnar, Vishal https://orcid.org/0000-0002-3584-7530
Phan, An
Yang, Lu https://orcid.org/0000-0001-7952-0399
Nelson, Michael S. https://orcid.org/0000-0003-0480-5597
Shukla, Ravi P.
Wang, Jinhui
Li, Aimin
Geng, Huimin
Lee, Jaewoong
Sadras, Teresa
Pham, Lan V.
Weisenburger, Dennis D.
Chan, Wing C. https://orcid.org/0000-0002-6243-6008
Lang, Karl S.
Shouse, Geoffrey P. https://orcid.org/0000-0002-7917-5713
Danilov, Alexey V. https://orcid.org/0000-0003-4461-0970
Song, Joo Y.
Parekh, Samir https://orcid.org/0000-0001-9694-8469
Müschen, Markus https://orcid.org/0000-0002-6064-8613
Ngo, Vu N. https://orcid.org/0000-0002-9501-6990
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R03CA245996, R01CA262754)
Article History
Received: 23 October 2024
Accepted: 19 May 2025
First Online: 29 May 2025
Competing interests
: S.P. serves on the Advisory Board at Grail, consults for Regeneron, Genentech/Roche, and Poseida Therapeutics, and receives research support from Grail, Celgene/BMS Corporation, Caribou, imCORE, and Poseida Therapeutics. The remaining authors declare no competing interests.